证券记录 · 已归档季度
GH
Guardant Health, Inc. · Healthcare · Medical - Diagnostics & Research
22被追踪持有人
+1Δ持有人
50.89M持有股份
$3.18B报告持仓市值
+2新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 +4.8% ·
股份流向 -4.7% ·
净新建仓位 0.0%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 45.42K | $7.92M | n/a | −1 |
| Q2 2026 | 137 | +11 | 93.62M | $13.95B | +17 | −7 |
| Q1 2026 | 130 | -8 | 97.95M | $8.77B | +5 | −14 |
| Q4 2025 | 137 | +1 | 99.79M | $9.86B | +2 | n/a |
| Q3 2025 | 22 | +1 | 50.89M | $3.18B | +2 | −2 |
| Q2 2025 | 19 | -1 | 51.15M | $2.66B | n/a | −1 |
| Q1 2025 | 17 | -1 | 25.07M | $1.07B | n/a | −1 |
| Q4 2024 | 18 | +2 | 25.10M | $766.76M | +2 | n/a |
| Q3 2024 | 15 | +1 | 25.31M | $580.70M | +2 | −1 |
| Q2 2024 | 14 | n/a | 24.13M | $697.01M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 11.91M | -2.1% | $744.06M | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 11.43M | +4.1% | $714.10M | 0.0% | ▲ Add | 2 | SEC ↗ ×21 |
| 3 | Baillie Gifford ✦ | 5.13M | +6.6% | $320.38M | 0.2% | ▲ Add | 6 | SEC ↗ ×4 |
| 4 | T. Rowe Price ✦ | 4.22M | +139.1% | $263.77M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 3.25M | +69.0% | $203.00M | 0.0% | ▲ Add | 6 | SEC ↗ ×9 |
| 6 | Geode Capital Management ✦ (被动) | 2.94M | +0.6% | $183.51M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | State Street Global Advisors ✦ (被动) | 2.79M | -1.8% | $174.18M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 1.80M | -2.8% | $112.67M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 9 | Goldman Sachs Group ✦ | 1.51M | n/a | $94.11M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 10 | JPMorgan Chase ✦ | 987.64K | n/a | $61.71M | 0.0% | n/c | 1 | SEC ↗ ×20 |
| 11 | Morgan Stanley ✦ | 982.54K | n/a | $61.39M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 12 | Millennium Management ✦ | 878.58K | -67.7% | $54.89M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 824.26K | -16.5% | $51.50M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 14 | ARK Investment Management ✦ | 795.23K | -71.8% | $49.69M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 531.85K | -21.2% | $33.23M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 304.52K | -89.6% | $19.03M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Marshall Wace ✦ | 241.31K | 新增 | $15.08M | 0.0% | New | 1 | SEC ↗ ×2 |
| 18 | Adage Capital Partners ✦ | 152.12K | -50.5% | $9.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 102.42K | +81.9% | $6.40M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 81.58K | +1.8% | $5.10M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 21 | D. E. Shaw & Co. ✦ | 33.35K | 新增 | $2.08M | 0.0% | New | 1 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 4.01K | +3.6% | $250,545 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $15.08M | 0.0% |
| D. E. Shaw & Co. | $2.08M | 0.0% |
已清仓
| Norges Bank | $64.14M | 曾为 0.0% |
| PRIMECAP Management | $3.43M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 481 持有人, 137.05M 股份, $11.53B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 16
Tariq Musa
Director · 116 股 · $19,242
Oct 14
Azar Alex M II
Director · 69 股 · $11,032
Sep 16
Krognes Steve E.
Director · 1.10K 股 · $192,432
Sep 16
Azar Alex M II
Director · 826 股 · $144,550
Sep 16
Krognes Steve E.
Director · 3.30K 股 · $578,888
Sep 16
Krognes Steve E.
Director · 1.30K 股 · $229,236
Sep 16
Krognes Steve E.
Director · 971 股 · $172,330
Sep 16
Tariq Musa
Director · 116 股 · $20,300
Sep 15
Chudova Darya
Officer · 7.74K 股 · $1.38M
Sep 11
Kalia Kumud
Officer · 4.00K 股 · $632,193
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A: PRICE T ROWE ASSOCIATES INC /MD/
Jul 28
SC 13G/A: BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据